Special report: left ventricular assist devices as destination therapy for end-stage heart failure--cost-effectiveness analysis.  [electronic resource] 

 -  TEC bulletin  Nov 2003 
 - 33-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1543-1622 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blue Cross Blue Shield Insurance Plans<br/>Cost-Benefit Analysis<br/>Device Approval<br/>Drug Approval<br/>Evidence-Based Medicine<br/>Heart Failure--surgery<br/>Heart Transplantation<br/>Heart-Assist Devices--economics<br/>Humans<br/>Insurance Coverage<br/>Outcome Assessment, Health Care<br/>Technology Assessment, Biomedical<br/>United States<br/>United States Food and Drug Administration